We did observe more undifferentiated sarcomas (Fig 2D) in the Esco2+/-; p53+/- mice cohort, however the timing of this tumor type was not statistically different suggesting this is not the driving force for the accelerated tumor onset. This evidence concerns the gene ESCO2 and neoplasm.